Sonoma Pharmaceuticals
SNOA
21 hedge funds and large institutions have $1.42M invested in Sonoma Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
59% more capital invested
Capital invested by funds: $890K → $1.42M (+$528K)
40% more funds holding
Funds holding: 15 → 21 (+6)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
+$134K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$133K |
| 3 |
Jane Street
New York
|
+$57.1K |
| 4 |
Morgan Stanley
New York
|
+$36.5K |
| 5 |
NL
NWAM LLC
Mercer Island,
Washington
|
+$25.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$352K |
| 2 |
VKH
Virtu KCG Holdings
New York
|
-$36K |
| 3 |
Creative Planning
Overland Park,
Kansas
|
-$20K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$14.1K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$12.2K |
SNOA Hedge Fund Activity: Q2 2015 in Review
21 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Sonoma Pharmaceuticals (SNOA) for Q2 2015, worth a combined $1.42M — up 59% from $890K a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new SNOA positions and 3 closed out — a net gain of 6 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Goldman Sachs, opening a new position worth an estimated $134K. The largest seller was Sabby Management, exiting entirely with an estimated $352K sold.
- 21 institutional investors held Sonoma Pharmaceuticals (SNOA) as of Q2 2015, up from 15 in Q1 2015.
- Funds reported $1.42M of Sonoma Pharmaceuticals stock for Q2 2015, up 59% quarter-over-quarter.
- 9 funds opened new Sonoma Pharmaceuticals positions in Q2 2015 and 3 closed out, a net change of +6 holders.
- The largest Sonoma Pharmaceuticals buyer in Q2 2015 was Goldman Sachs, an estimated $134K added.
- The largest Sonoma Pharmaceuticals seller in Q2 2015 was Sabby Management, an estimated $352K sold.
Based on aggregated 13F filings for Q2 2015.